![Prasanna Balaprakash](/sites/default/files/styles/featured_square_large/public/2024-08/2023-P02525.jpg?h=502e75fa&itok=ePVQC-A5)
Filter News
Area of Research
- (-) Biology and Environment (25)
- (-) Neutron Science (16)
- Advanced Manufacturing (22)
- Biological Systems (1)
- Building Technologies (1)
- Clean Energy (82)
- Computational Biology (2)
- Computational Engineering (1)
- Fusion and Fission (4)
- Fusion Energy (1)
- Isotopes (5)
- Materials (28)
- Materials for Computing (4)
- National Security (4)
- Nuclear Science and Technology (6)
- Supercomputing (21)
News Topics
- (-) 3-D Printing/Advanced Manufacturing (15)
- (-) Biomedical (26)
- Advanced Reactors (2)
- Artificial Intelligence (14)
- Big Data (10)
- Bioenergy (50)
- Biology (75)
- Biotechnology (13)
- Buildings (2)
- Chemical Sciences (13)
- Clean Water (13)
- Climate Change (41)
- Composites (5)
- Computer Science (31)
- Coronavirus (18)
- Critical Materials (1)
- Cybersecurity (1)
- Decarbonization (21)
- Energy Storage (13)
- Environment (97)
- Exascale Computing (4)
- Fossil Energy (1)
- Frontier (4)
- Fusion (1)
- Grid (3)
- High-Performance Computing (22)
- Hydropower (8)
- Isotopes (2)
- Machine Learning (10)
- Materials (25)
- Materials Science (28)
- Mathematics (3)
- Mercury (7)
- Microscopy (13)
- Molten Salt (1)
- Nanotechnology (17)
- National Security (5)
- Net Zero (2)
- Neutron Science (99)
- Nuclear Energy (4)
- Partnerships (5)
- Physics (11)
- Polymers (3)
- Quantum Computing (1)
- Quantum Science (7)
- Renewable Energy (1)
- Security (4)
- Simulation (14)
- Space Exploration (3)
- Summit (15)
- Sustainable Energy (32)
- Transformational Challenge Reactor (1)
- Transportation (8)
Media Contacts
![Technology Innovation Program](/sites/default/files/styles/list_page_thumbnail/public/2022-08/TIPbg_0.jpg?h=a50b7bdc&itok=_3vRlbkP)
Five technologies invented by scientists at the Department of Energy’s Oak Ridge National Laboratory have been selected for targeted investment through ORNL’s Technology Innovation Program.
![MDF Exterior](/sites/default/files/styles/list_page_thumbnail/public/2022-06/2021-p07609.jpg?h=be3e4b3a&itok=YfKK7Wy2)
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
![An artist's rendering of the Ultium Cells battery cell production facility to be built in Spring Hill, Tennessee, which will employ 1,300 people. Recognizing the unique expertise of their organizations, ORNL, TVA, and the Tennessee Department of Economic and Community Development have been working together for several years to bring startups developing battery technologies for EVs and established automotive firms to Tennessee. Credit: Ultium Cells](/sites/default/files/styles/list_page_thumbnail/public/2022-02/UltiumCellsLLC-SpringHill-TN-Rendering_0.jpg?h=f9f6f138&itok=_TJq1Ajl)
ORNL, TVA and TNECD were recognized by the Federal Laboratory Consortium for their impactful partnership that resulted in a record $2.3 billion investment by Ultium Cells, a General Motors and LG Energy Solution joint venture, to build a battery cell manufacturing plant in Spring Hill, Tennessee.
![Ten scientists from the Department of Energy’s Oak Ridge National Laboratory are among the world’s most highly cited researchers. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-11/2008-P01679_0.jpg?h=6acbff97&itok=ewBiiftq)
Ten scientists from the Department of Energy’s Oak Ridge National Laboratory are among the world’s most highly cited researchers, according to a bibliometric analysis conducted by the scientific publication analytics firm Clarivate.
![Researchers studying secondary metabolites in the fungus Aspergillus flavus, pictured, found unique mixes of metabolites corresponding to genetically distinct populations. The finding suggests local environmental conditions play a key role in secondary metabolite production, influencing the discovery of drugs and other useful compounds. Credit: Tomás Allen Rush/ORNL, U.S. Dept. of Energy.](/sites/default/files/styles/list_page_thumbnail/public/2021-07/DSC0351.jpg?h=b2d9f031&itok=PNgYY5eW)
Scientists at ORNL and the University of Wisconsin–Madison have discovered that genetically distinct populations within the same species of fungi can produce unique mixes of secondary metabolites, which are organic compounds with applications in
![An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus. Credit: Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-06/frame1.png?h=d1cb525d&itok=51pwBWyP)
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
![Belinda Akpa applies her diverse expertise and high-performance computing to accelerate the drug discovery process and increase the chances of success when candidate molecules go to clinical trials. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02772_1.jpg?h=0a8b6f8b&itok=seLu5znj)
Belinda Akpa is a chemical engineer with a talent for tackling big challenges and fostering inclusivity and diversity in the next generation of scientists.
![Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.](/sites/default/files/styles/list_page_thumbnail/public/2021-04/2021-P02194_small.jpg?h=c6980913&itok=bc6MRBX6)
Rich Giannone uses bioanalytical mass spectrometry to examine proteins, the primary driver in biological systems.
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.
![Neutron scattering experiments show electric charges, shown in red, blue and grey, in the SARS-CoV-2 main protease site where telaprevir binds to the structure. The experiments provide critical data for the design of small-molecule drugs to treat COVID-19. Credit: Jill Hemman and Michelle Lehman/ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-03/after_transprent_background-wFill.png?h=c71d0c67&itok=jGFt_Ggj)
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.